Recombinant SLAMF7 (Elotuzumab Biosimilar) antibody (Alexa Fluor 488)
The Humanized Monoclonal anti-SLAMF7 (Elotuzumab Biosimilar) antibody has been validated for ELISA, FACS and CyTox. It is suitable to detect SLAMF7 (Elotuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7766299
$515.90
Plus shipping costs $50.00
100 μL
Shipping to:
United States
Delivery in 6 to 8 Business Days
Quick Overview for Recombinant SLAMF7 (Elotuzumab Biosimilar) antibody (Alexa Fluor 488) (ABIN7766299)
Target
SLAMF7 (Elotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This SLAMF7 (Elotuzumab Biosimilar) antibody is conjugated to Alexa Fluor 488
Application
ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)
-
-
Purpose
- Conjugated Anti-CS1 (elotuzumab biosimilar) mAb
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
-
-
-
Application Notes
- most applications: 1: 50 - 1: 250
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Protect from light!
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C in dark for 6 months
-
-
- SLAMF7 (Elotuzumab Biosimilar)
-
Alternative Name
- elotuzumab biosimilar
-
Target Type
- Biosimilar
-
Background
- CS1, CD319, SLAMF7, CRACC
Target
-
You are here:
